ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,698,523 | +42.1% | 81,503 | -3.9% | 0.02% | -45.2% |
| Q2 2022 | $1,195,000 | +11.2% | 84,833 | +84.2% | 0.03% | +72.2% |
| Q4 2021 | $1,075,000 | +188.2% | 46,063 | +104.9% | 0.02% | +200.0% |
| Q3 2021 | $373,000 | -55.7% | 22,483 | -31.1% | 0.01% | -64.7% |
| Q1 2021 | $842,000 | +267.7% | 32,635 | +663.4% | 0.02% | +183.3% |
| Q4 2020 | $229,000 | +10.6% | 4,275 | +0.3% | 0.01% | -40.0% |
| Q2 2020 | $207,000 | -89.2% | 4,264 | -90.5% | 0.01% | -88.4% |
| Q4 2019 | $1,916,000 | -60.7% | 44,793 | -66.9% | 0.09% | -48.5% |
| Q3 2019 | $4,872,000 | +377.6% | 135,365 | +114.6% | 0.17% | +735.0% |
| Q4 2018 | $1,020,000 | -23.8% | 63,082 | -28.1% | 0.02% | -57.4% |
| Q2 2018 | $1,339,000 | -14.3% | 87,705 | +69.1% | 0.05% | +17.5% |
| Q4 2017 | $1,562,000 | +232.3% | 51,869 | +207.9% | 0.04% | +185.7% |
| Q2 2017 | $470,000 | -8.6% | 16,847 | +17.0% | 0.01% | 0.0% |
| Q4 2015 | $514,000 | +1.4% | 14,405 | -6.0% | 0.01% | -17.6% |
| Q3 2015 | $507,000 | -36.1% | 15,327 | -19.2% | 0.02% | -26.1% |
| Q2 2015 | $794,000 | +198.5% | 18,969 | +76.5% | 0.02% | +130.0% |
| Q3 2014 | $266,000 | – | 10,748 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |